Evaluation of Colombian silk fibroin hydrogels functionalized with recombinant LSECtin for intervertebral disc tissue engineering.
Caballero-Méndez LC., Zuluaga-Vélez A., Melchor-Moncada JJ., Quintero-Martinez A., Mongeau L., Nejati S.
Animal Study on Disc Degeneration, published in PLoS One (2026) — summary generated from the PubMed abstract.
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- PLoS One (2026)
- Country
- United States
- Reported sample size
- —
- PMID
- 42139309
- DOI
- 10.1371/journal.pone.0349634
Abstract (original English)
This study evaluated the potential of Colombian silk fibroin hydrogels functionalized with recombinant LSECtin (rLSECtin) for intervertebral disc tissue engineering. In silico analysis indicated that rLSECtin may interact with glycans similar to those found in human adipose-derived stem cells (ADSCs) through residues Asn105, Asp106, Glu93, Asn87, and Glu85, which coordinate calcium to form hydrogen bonds with GlcNAc hydroxyl groups. rLSECtin was successfully produced, purified, and incorporated into silk fibroin hydrogels. Thermal analysis showed that the hydrogels were resistant to sterilization, and rheological studies demonstrated predominantly elastic, gel-like behavior. The secondary structure of the hydrogels was largely determined by α-helical content, which is related to silk I with β-sheets also contributing as a result of sonication-induced structuring. Metabolic activity assays indicated that rLSECtin was associated with increased ADSC metabolic activity under two-dimensional conditions, whereas hydrogels containing rLSECtin maintained cell viability, as confirmed by cell viability assays. Differentiated constructs exhibited glycosaminoglycan-rich extracellular matrix and chondrocyte-like morphology, whereas rLSECtin-functionalized hydrogels showed increased transcription of SOX9, ACAN, and COL2A1, along with elevated COL10A1 of uncertain significance for nucleus pul
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence comes from animal or laboratory studies and has not been confirmed in humans.
How we grade evidenceRelated research
- Level ASystematic Review
Mesenchymal Stromal Cells for the Treatment of Discogenic Low Back Pain: A Systematic Review of Clinical Studies.
Systematic Review with a reported sample of 736 on Back Pain, Disc Degeneration, published in Neurospine (2025) — summary generated from the PubMed abstract.
- 2025
- n = 736
Neurospine - Level ASystematic Review
Stem cells and discogenic back pain.
Systematic Review with a reported sample of 303 on Back Pain, Disc Degeneration, published in Br Med Bull (2023) — summary generated from the PubMed abstract.
- 2023
- n = 303
Br Med Bull - Level ASystematic Review
Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review.
Systematic Review on Back Pain, Disc Degeneration, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci - Level ASystematic Review
Mesenchymal Stem Cell Levels of Human Spinal Tissues.
Systematic Review on Ligament Injury, Disc Degeneration, published in Spine (Phila Pa 1976) (2018) — summary generated from the PubMed abstract.
- 2018
Spine (Phila Pa 1976) - Level ASystematic Review
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics.
Systematic Review on Back Pain, Disc Degeneration, published in Stem Cells Dev (2014) — summary generated from the PubMed abstract.
- 2014
Stem Cells Dev - Level BRandomized Controlled Trial
Cell-Free Fat Extract (CEFFE) as a Versatile Cell-Free Biologic for Multitissue Regeneration: From Skin and Bone to Nerve, Reproductive, and Systemic Applications-A Comprehensive Review.
Randomized Controlled Trial on Osteoarthritis, Disc Degeneration, Neuroinflammation, Chronic Wound, published in Biomed Res Int (2026) — summary generated from the PubMed abstract.
- 2026
Biomed Res Int